Silver Book Fact

According to the Pharmaceutical Research and Manufacturers of America, a medicine in development targets late-stage metastatic melanoma. The medicine contains a gene encoding antigen that may be able to alert the immune system when there is a foreign tissue present. This would in turn induce a powerful immune response.

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • According to the Pharmaceutical Research and Manufacturers of America, a medicine currently in development may delay the worsening of liver cancer. The medicine is an oral signal transduction inhibitor…  
  • Investments in research since the 1970s have generated $1.9 trillion of value to society overall.  
  • FDA approved cancer advances
     
  • Following the current path, the lung cancer incidence rate will increase by 34% between 2003 and 2023. If an alternative path is taken, there will be 18.4% (92,000) fewer lung…  
  • Since 1980, 83 percent of gains in life expectancy for cancer patients have been attributable to new treatments.